Effect of venovenous extracorporeal membrane oxygenation on the heart in a healthy piglet model

Journal of Cardiothoracic Surgery

Volumn 8, Issue 1, 2013, Pages

  Shen, Juanhong ^a   Yu, Wenkui ^a   Shi, Jialiang ^a   Chen, Qiyi ^a   Hu, Yimin ^a   Zhang, Juanjuan ^a   Gao, Tao ^a   Xi, Fengchan ^a   Gong, Jianfeng ^a   He, Changsheng ^a   Li, Ning ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; EXTRACORPOREAL OXYGENATION; FEMALE; HEART; HEART MUSCLE; HEMODYNAMICS; MALE; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG; ULTRASTRUCTURE;

ANIMALS; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART; HEMODYNAMICS; MALE; MITOCHONDRIA; MYOCARDIUM; SWINE;

EID: 84879424749     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-8-163     Document Type: Article

References (38)

1. Maclaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med 2012, 38:210-220. 10.1007/s00134-011-2439-2, 22147116.
2. Tiruvoipati R, Botha J, Peek G. Effectiveness of extracorporeal membrane oxygenation when conventional ventilation fails: valuable option or vague remedy?. J Crit Care 2012, 27:192-198. 10.1016/j.jcrc.2011.04.003, 21703814.
3. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009, 374:1351-1363. 10.1016/S0140-6736(09)61069-2, 19762075.
4. Noah MA, Peek GJ, Finney SJ, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 2011, 306:1659-1668. 10.1001/jama.2011.1471, 21976615.
5. Dalton HJ. Extracorporeal life support: moving at the speed of light. Respir Care 2011, 56:1445-1453. 10.4187/respcare.01369, 21944690.
6. Brogan TV, Thiagarajan RR, Rycus PT, Bartlett RH, Bratton SL. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med 2009, 35:2105-2114. 10.1007/s00134-009-1661-7, 19768656.
7. Zabrocki LA, Brogan TV, Statler KD, Poss WB, Rollins MD, Bratton SL. Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality. Crit Care Med 2011, 39:364-370. 10.1097/CCM.0b013e3181fb7b35, 20959787.
8. Schmid C, Philipp A, Hilker M, et al. Venovenous extracorporeal membrane oxygenation for acute lung failure in adults. J Heart Lung Transplant 2012, 31:9-15. 10.1016/j.healun.2011.07.013, 21885295.
9. Strieper MJ, Sharma S, Dooley KJ, Cornish JD, Clark RH. Effects of venovenous extracorporeal membrane oxygenation on cardiac performance as determined by echocardiographic measurements. J Pediatr 1993, 122:950-955. 10.1016/S0022-3476(09)90026-9, 8501576.
10. Roberts N, Westrope C, Pooboni SK, et al. Venovenous extracorporeal membrane oxygenation for respiratory failure in inotrope dependent neonates. ASAIO J 2003, 49:568-571. 10.1097/01.MAT.0000084102.22059.91, 14524566.
11. Zimmerman GA, Morris AH, Cengiz M. Cardiovascular alterations in the adult respiratory distress syndrome. Am J Med 1982, 73:25-34. 10.1016/0002-9343(82)90920-2, 7091171.
12. Bajwa EK, Boyce PD, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome. Crit Care Med 2007, 35:2484-2490. 10.1097/01.CCM.0000281852.36573.22, 18084839.
13. Poderoso JJ, Carreras MC, Lisdero C, Riobo N, Schopfer F, Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 1996, 328:85-92. 10.1006/abbi.1996.0146, 8638942.
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254. 10.1016/0003-2697(76)90527-3, 942051.
15. Sudheesh NP, Ajith TA, Janardhanan KK. Ganoderma lucidum (Fr.) P. Karst enhances activities of heart mitochondrial enzymes and respiratory chain complexes in the aged rat. Biogerontology 2009, 10:627-636. 10.1007/s10522-008-9208-9, 19123066.
16. Golej J, Kahlbacher H, Schoffmann G, et al. The immediate haemodynamic response to the initiation of extracorporeal membrane oxygenation in a piglet model of infant hypoxic respiratory failure. Perfusion 2002, 17:421-426. 10.1191/0267659102pf609oa, 12470031.
17. Hirthler M, Simoni J, Dickson M. Elevated levels of endotoxin, oxygen-derived free radicals, and cytokines during extracorporeal membrane oxygenation. J Pediatr Surg 1992, 27:1199-1202. 10.1016/0022-3468(92)90787-8, 1432529.
18. Underwood MJ, Pearson JA, Waggoner J, Lunec J, Firmin RK, Elliot MJ. Changes in "inflammatory" mediators and total body water during extra-corporeal membrane oxygenation (ECMO). A preliminary study. Int J Artif Organs 1995, 18:627-632.
19. Fortenberry JD, Bhardwaj V, Niemer P, Cornish JD, Wright JA, Bland L. Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation. J Pediatr 1996, 128:670-678. 10.1016/S0022-3476(96)80133-8, 8627440.
20. Adrian K, Mellgren K, Skogby M, Friberg LG, Mellgren G, Wadenvik H. Cytokine release during long-term extracorporeal circulation in an experimental model. Artif Organs 1998, 22:859-863. 10.1046/j.1525-1594.1998.06121.x, 9790084.
21. Mu TS, Palmer EG, Batts SG, Lentz-Kapua SL, Uyehara-Lock JH, Uyehara CF. Continuous renal replacement therapy to reduce inflammation in a piglet hemorrhage-reperfusion extracorporeal membrane oxygenation model. Pediatr Res 2012, 72:249-255. 10.1038/pr.2012.69, 22669297.
22. Mann DL. The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines. J Card Fail 1996, 2:S165-S172.
23. Ungureanu-Longrois D, Balligand JL, Kelly RA, Smith TW. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 1995, 27:155-167. 10.1016/S0022-2828(08)80015-6, 7539082.
24. Zhang M, Chen L. Status of cytokines in ischemia reperfusion induced heart injury. Cardiovasc Hematol Disord Drug Targets 2008, 8:161-172. 10.2174/187152908785849116, 18781928.
25. Deng MC, Dasch B, Erren M, Mollhoff T, Scheld HH. Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. Ann Thorac Surg 1996, 62:184-190. 10.1016/0003-4975(96)00230-5, 8678641.
26. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994, 108:626-635.
27. Liakopoulos OJ, Teucher N, Muhlfeld C, et al. Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment. Eur J Cardiothorac Surg 2006, 30:263-270. 10.1016/j.ejcts.2006.04.019, 16829094.
28. Cavarocchi NC, England MD, Schaff HV, et al. Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation. Circulation 1986, 74:III130-III133.
29. Clermont G, Vergely C, Jazayeri S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology 2002, 96:80-87. 10.1097/00000542-200201000-00019, 11753006.
30. Moller J, Gilman JT, Sussmane J, Raszynski A, Wolfsdorf J. Changes in plasma levels of oxygen radical scavenging enzymes during extracorporeal membrane oxygenation in a lamb model. Biol Neonate 1993, 64:134-139. 10.1159/000243983, 8260545.
31. Kevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg 2005, 101:1275-1287. 10.1213/01.ANE.0000180999.81013.D0, 16243980.
32. Jain M, Cui L, Brenner DA, et al. Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation 2004, 109:898-903. 10.1161/01.CIR.0000112605.43318.CA, 14757696.
33. Tsai MS, Huang CH, Tsai CY, et al. Ascorbic acid mitigates the myocardial injury after cardiac arrest and electrical shock. Intensive Care Med 2011, 37:2033-2040. 10.1007/s00134-011-2362-6, 21953354.
34. Karle VA, Short BL, Martin GR, et al. Extracorporeal membrane oxygenation exposes infants to the plasticizer, di(2-ethylhexyl)phthalate. Crit Care Med 1997, 25:696-703. 10.1097/00003246-199704000-00023, 9142038.
35. Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol 2004, 555:1-13. 1664831, 14660709.
36. Shen I, Levy FH, Benak AM, et al. Left ventricular dysfunction during extracorporeal membrane oxygenation in a hypoxemic swine model. Ann Thorac Surg 2001, 71:868-871. 10.1016/S0003-4975(00)02281-5, 11269466.
37. Allen BS, Rahman S, Ilbawi MN, et al. Detrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury. Ann Thorac Surg 1997, 64:1381-1388. 10.1016/S0003-4975(97)00905-3, 9386708.
38. Trittenwein G, Rotta AT, Gunnarsson B, Steinhorn DM. Lipid peroxidation during initiation of extracorporeal membrane oxygenation after hypoxia in endotoxemic rabbits. Perfusion 1999, 14:49-57. 10.1177/026765919901400108, 10074647.